Jean-Yves Reginster (J-Y Reginster, Jean Yves Reginster)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 63

Top Topics

Knee Osteoarthritis

Hyaluronic Acid

Systematic Review

Postmenopausal Women

Top Venues

Aging clinical and experimental research

Journal of cachexia, sarcopenia and muscle

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

This page only lists publications with an associated author ORCID identifier.

Publications

Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
John A Kanis, Bess Dawson-Hughes, Claudia Campusano, Cyrus Cooper, Peter R Ebeling, Philippe Halbout, Nicholas C W Harvey, Eugene V McCloskey, Michael R McClung, Jean-Yves Reginster, Yousef Saleh, Leith Zakraoui, Famida Jiwa
IOF position on scientists and societies operating in conflict zones. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (8) (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
Anhye Kim, Jang Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
John A Kanis, Bess Dawson-Hughes, Claudia Campusano, Cyrus Cooper, Peter R Ebeling, Philippe Halbout, Nicholas C W Harvey, Eugene V McCloskey, Michael R McClung, Jean-Yves Reginster, Yousef Saleh, Leith Zakraoui, Famida Jiwa
IOF position on scientists and societies operating in conflict zones. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (8) (2024)
Jean-Yves Reginster, Edward Czerwinski, Krzysztof Wilk, Przemysław Borowy, Anna Strzelecka, Tomasz Budlewski, Monika Janowska-Maus, Krzysztof Szymanowski, Joanna Kwiatek, Svitlana Postol, Airi Põder, Jerzy Supronik, SungHyun Kim, JeeHye Suh, NooRi Han, NaHyun Kim, SeoHee Bae, Stuart L Silverman
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
John A Kanis, Bess Dawson-Hughes, Claudia Campusano, Cyrus Cooper, Peter R Ebeling, Philippe Halbout, Nicholas C W Harvey, Eugene V McCloskey, Michael R McClung, Jean-Yves Reginster, Yousef Saleh, Leith Zakraoui, Famida Jiwa
IOF position on scientists and societies operating in conflict zones. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
John A Kanis, Nicholas C Harvey, Mattias Lorentzon, Enwu Liu, Marian Schini, Bo Abrahamsen, Jonathan D Adachi, Majed Alokail, Fredrik Borgstrom, Olivier Bruyère, John J Carey, Patricia Clark, Cyrus Cooper, Elizabeth M Curtis, Elaine M Dennison, Manuel Díaz-Curiel, Hans P Dimai, Daniel Grigorie, Mickael Hiligsmann, Patricia Khashayar, Willem Lems, E Michael Lewiecki, Roman S Lorenc, Alexandra Papaioannou, Jean-Yves Reginster, René Rizzoli, Eric Shiroma, Stuart L Silverman, Eleanor Simonsick, Manuel Sosa-Henríquez, Pawel Szulc, Kate A Ward, Noriko Yoshimura, Helena Johansson, Liesbeth Vandenput, Eugene V McCloskey, null null
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (9) (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Céline Demonceau, B Voz, Olivier Bruyère, Jean-Yves Reginster, Charlotte Beaudart
Content validity of SarQoL, a quality of life questionnaire specific to sarcopenia. Aging clinical and experimental research 36 (1) (2024)
Leo D Westbury, Nicholas C W Harvey, Charlotte Beaudart, Olivier Bruyère, Jane A Cauley, Peggy M Cawthon, Alfonso J Cruz-Jentoft, Elizabeth M Curtis, Kristine E Ensrud, Roger A Fielding, Helena Johansson, John A Kanis, Magnus K Karlsson, Nancy E Lane, Laetitia Lengelé, Mattias Lorentzon, Eugene V McCloskey, Dan Mellström, Anne B Newman, Claes Ohlsson, Eric S Orwoll, Jean-Yves Reginster, Eva Ribom, Björn E Rosengren, John T Schousboe, Elaine M Dennison, Cyrus Cooper, null null
Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts. Aging clinical and experimental research 36 (1) (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Leo D Westbury, Nicholas C W Harvey, Charlotte Beaudart, Olivier Bruyère, Jane A Cauley, Peggy M Cawthon, Alfonso J Cruz-Jentoft, Elizabeth M Curtis, Kristine E Ensrud, Roger A Fielding, Helena Johansson, John A Kanis, Magnus K Karlsson, Nancy E Lane, Laetitia Lengelé, Mattias Lorentzon, Eugene V McCloskey, Dan Mellström, Anne B Newman, Claes Ohlsson, Eric S Orwoll, Jean-Yves Reginster, Eva Ribom, Björn E Rosengren, John T Schousboe, Elaine M Dennison, Cyrus Cooper, null null
Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts. Aging clinical and experimental research 36 (1) (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
Emma Calluy, Charlotte Beaudart, Majed S Alokail, Nasser M Al-Daghri, Olivier Bruyère, Jean-Yves Reginster, Cavalier Etienne, Aurélie Ladang
Confounding factors of the expression of mTBI biomarkers, S100B, GFAP and UCH-L1 in an aging population. Clinical chemistry and laboratory medicine (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Leo D Westbury, Nicholas C W Harvey, Charlotte Beaudart, Olivier Bruyère, Jane A Cauley, Peggy M Cawthon, Alfonso J Cruz-Jentoft, Elizabeth M Curtis, Kristine E Ensrud, Roger A Fielding, Helena Johansson, John A Kanis, Magnus K Karlsson, Nancy E Lane, Laetitia Lengelé, Mattias Lorentzon, Eugene V McCloskey, Dan Mellström, Anne B Newman, Claes Ohlsson, Eric S Orwoll, Jean-Yves Reginster, Eva Ribom, Björn E Rosengren, John T Schousboe, Elaine M Dennison, Cyrus Cooper, null null
Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts. Aging clinical and experimental research 36 (1) (2024)
John A Kanis, Nicholas C Harvey, Mattias Lorentzon, Enwu Liu, Marian Schini, Bo Abrahamsen, Jonathan D Adachi, Majed Alokail, Fredrik Borgstrom, Olivier Bruyère, John J Carey, Patricia Clark, Cyrus Cooper, Elizabeth M Curtis, Elaine M Dennison, Manuel Díaz-Curiel, Hans P Dimai, Daniel Grigorie, Mickael Hiligsmann, Patricia Khashayar, Willem Lems, E Michael Lewiecki, Roman S Lorenc, Alexandra Papaioannou, Jean-Yves Reginster, René Rizzoli, Eric Shiroma, Stuart L Silverman, Eleanor Simonsick, Manuel Sosa-Henríquez, Pawel Szulc, Kate A Ward, Noriko Yoshimura, Helena Johansson, Liesbeth Vandenput, Eugene V McCloskey, null null
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (9) (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle (2024)
John A Kanis, Nicholas C Harvey, Mattias Lorentzon, Enwu Liu, Marian Schini, Bo Abrahamsen, Jonathan D Adachi, Majed Alokail, Fredrik Borgstrom, Olivier Bruyère, John J Carey, Patricia Clark, Cyrus Cooper, Elizabeth M Curtis, Elaine M Dennison, Manuel Díaz-Curiel, Hans P Dimai, Daniel Grigorie, Mickael Hiligsmann, Patricia Khashayar, Willem Lems, E Michael Lewiecki, Roman S Lorenc, Alexandra Papaioannou, Jean-Yves Reginster, René Rizzoli, Eric Shiroma, Stuart L Silverman, Eleanor Simonsick, Manuel Sosa-Henríquez, Pawel Szulc, Kate A Ward, Noriko Yoshimura, Helena Johansson, Liesbeth Vandenput, Eugene V McCloskey, null null
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
Céline Demonceau, B Voz, Olivier Bruyère, Jean-Yves Reginster, Charlotte Beaudart
Content validity of SarQoL, a quality of life questionnaire specific to sarcopenia. Aging clinical and experimental research 36 (1) (2024)
Leo D Westbury, Nicholas C W Harvey, Charlotte Beaudart, Olivier Bruyère, Jane A Cauley, Peggy M Cawthon, Alfonso J Cruz-Jentoft, Elizabeth M Curtis, Kristine E Ensrud, Roger A Fielding, Helena Johansson, John A Kanis, Magnus K Karlsson, Nancy E Lane, Laetitia Lengelé, Mattias Lorentzon, Eugene V McCloskey, Dan Mellström, Anne B Newman, Claes Ohlsson, Eric S Orwoll, Jean-Yves Reginster, Eva Ribom, Björn E Rosengren, John T Schousboe, Elaine M Dennison, Cyrus Cooper, null null
Predictive value of sarcopenia components for all-cause mortality: findings from population-based cohorts. Aging clinical and experimental research 36 (1) (2024)
John A Kanis, Bess Dawson-Hughes, Claudia Campusano, Cyrus Cooper, Peter R Ebeling, Philippe Halbout, Nicholas C W Harvey, Eugene V McCloskey, Michael R McClung, Jean-Yves Reginster, Yousef Saleh, Leith Zakraoui, Famida Jiwa
IOF position on scientists and societies operating in conflict zones. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (8) (2024)
Emma Calluy, Charlotte Beaudart, Majed S Alokail, Nasser M Al-Daghri, Olivier Bruyère, Jean-Yves Reginster, Cavalier Etienne, Aurélie Ladang
Confounding factors of the expression of mTBI biomarkers, S100B, GFAP and UCH-L1 in an aging population. Clinical chemistry and laboratory medicine (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Colin Vendrami, Enisa Shevroja, Elena Gonzalez Rodriguez, Guillaume Gatineau, Jolanda Elmers, Jean-Yves Reginster, Nicholas C W Harvey, Olivier Lamy, Didier Hans
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review. Journal of cachexia, sarcopenia and muscle 15 (2) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
Céline Demonceau, B Voz, Olivier Bruyère, Jean-Yves Reginster, Charlotte Beaudart
Content validity of SarQoL, a quality of life questionnaire specific to sarcopenia. Aging clinical and experimental research 36 (1) (2024)
Olivier Bruyère, Johann Detilleux, Jean-Yves Reginster
Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand. Medicines (Basel, Switzerland) 10 (3) (2023)
Olivier Bruyère, Johann Detilleux, Jean-Yves Reginster
Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand. Medicines (Basel, Switzerland) 10 (3) (2023)
Olivier Bruyère, Johann Detilleux, Jean-Yves Reginster
Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand. Medicines (Basel, Switzerland) 10 (3) (2023)
Olivier Bruyère, Johann Detilleux, Jean-Yves Reginster
Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand. Medicines (Basel, Switzerland) 10 (3) (2023)
Rebecca Jane Moon, Jean-Yves Reginster, Nasser M Al-Daghri, Jotheeswaran A Thiyagarajan, Charlotte Beaudart, Olivier Bruyère, Nansa Burlet, Manju Chandran, Mario Coelho da Silva, Philip Gerard Conaghan, Willard H Dere, Adolfo Diez-Perez, Peyman Hadji, Philippe Halbout, Mickaël J C Hiligsmann, John A Kanis, Eugene V McCloskey, Sif Ormarsdottir, Daniel Prieto-Alhambra, Régis Pierre Radermecker, René Rizzoli, Yousef Al Saleh, Stuart L Silverman, Lee S Simon, Friederike Thomasius, Tjeerd Pieter van Staa, Andrea Laslop, Cyrus Cooper, Nicholas C W Harvey
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Enisa Shevroja, Jean-Yves Reginster, Olivier Lamy, Nasser M Al-Daghri, Manju Chandran, Anne-Laurence Demoux, Lynn Kohlmeier, Marie-Paule Lecart, Osvaldo Daniel Messina, Bruno Muzzi Camargos, Juraj Payer, Sansin Tuzun, Nicola Veronese, Cyrus Cooper, Eugene V McCloskey, Nicholas C W Harvey
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Fanny Buckinx, Lucie Maton, Valentine Dalimier, Alexandre Mouton, Laetitia Lengelé, Jean-Yves Reginster, Olivier Bruyère
Development and Validation of New Exercises to Promote Physical Activity in Nursing Home Settings. Geriatrics (Basel, Switzerland) 7 (5) (2022)
Elizabeth M Curtis, Jean-Yves Reginster, Nasser M Al-Daghri, Emmanuel Biver, Maria Luisa Brandi, Cavalier Etienne, Peyman Hadji, Philippe Halbout, Nicholas C W Harvey, Mickaël J C Hiligsmann, Muhammad Kassim Javaid, John A Kanis, Jean-Marc Kaufman, Olivier Lamy, Radmila Matijevic, Adolfo Diez Perez, Régis Pierre Radermecker, Mário Miguel Rosa, Thierry Thomas, Friederike Thomasius, Mila Vlaskovska, René Rizzoli, Cyrus Cooper
Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging clinical and experimental research 34 (4) (2022)
Nicola Veronese, Germain Honvo, Jotheeswaran Amuthavalli Thiyagarajan, René Rizzoli, Cyrus Cooper, Olivier Bruyère, Christopher Mikton, Yuka Sumi, Theresa Diaz, Jean-Yves Reginster, Anshu Banerjee, null null
Attributes and definitions of locomotor capacity in older people: a World Health Organisation (WHO) locomotor capacity working group meeting report. Aging clinical and experimental research 34 (3) (2022)
Gülistan Bahat, Nezahat Muge Catikkas, Dilek Gogas Yavuz, Pınar Borman, Rengin Güzel, Jean-Yves Reginster
The current situation in the approach to osteoporosis in older adults in Turkey: areas in need of improvement with a model for other populations. Archives of osteoporosis 16 (1) (2021)
Gülistan Bahat, Nezahat Muge Catikkas, Mehmet Akif Karan, Jean-Yves Reginster
Orthogeriatrics: a vital requirement for improving fragility fracture patient care internationally with particular reference to Turkey. Archives of osteoporosis 16 (1) (2021)
Dolores Sanchez-Rodriguez, Médéa Locquet, Jean-Yves Reginster, Cavalier Etienne, Olivier Bruyère, Charlotte Beaudart
Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study. Journal of cachexia, sarcopenia and muscle 11 (5) (2020)
Jean-Yves Reginster, Nicola Veronese
Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment. Aging clinical and experimental research 33 (1) (2020)
Elizabeth M Curtis, Nicholas Fuggle, Sarah Shaw, Laura Spooner, Georgia Ntani, Camille Parsons, Nadia Corp, Germain Honvo, Janis Baird, Stefania Maggi, Elaine Dennison, Olivier Bruyère, Jean-Yves Reginster, Cyrus Cooper
Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs & aging 36 (Suppl 1) (2019)
Nicholas Fuggle, Elizabeth M Curtis, Sarah Shaw, Laura Spooner, Olivier Bruyère, Georgia Ntani, Camille Parsons, Philip G Conaghan, Nadia Corp, Germain Honvo, Daniel Uebelhart, Janis Baird, Elaine Dennison, Jean-Yves Reginster, Cyrus Cooper
Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs & aging 36 (Suppl 1) (2019)
Weibo Xia, Cyrus Cooper, Mei Li, Ling Xu, Rene Rizzoli, Mei Zhu, Hua Lin, John Beard, Yue Ding, Wei Yu, Etienne Cavalier, Zhenlin Zhang, John A Kanis, Qun Cheng, Quimei Wang, Jean-Yves Reginster
East meets West: current practices and policies in the management of musculoskeletal aging. Aging clinical and experimental research 31 (10) (2019)
Cyrus Cooper, Roland Chapurlat, Nasser Al-Daghri, Gabriel Herrero-Beaumont, Olivier Bruyère, François Rannou, Roland Roth, Daniel Uebelhart, Jean-Yves Reginster
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say? Drugs & aging 36 (Suppl 1) (2019)
Maarten de Wit, Cyrus Cooper, Peter Tugwell, Nathalie Bere, John Kirwan, Philip G Conaghan, Charlotte Roberts, Isabelle Aujoulat, Nasser Al-Daghri, Islene Araujo de Carvalho, Mary Barker, Nicola Bedlington, Maria Luisa Brandi, Olivier Bruyère, Nansa Burlet, Philippe Halbout, Mickaël Hiligsmann, Famida Jiwa, John A Kanis, Andrea Laslop, Wendy Lawrence, Daniel Pinto, Concepción Prieto Yerro, Véronique Rabenda, René Rizzoli, Marieke Scholte-Voshaar, Mila Vlaskovska, Jean-Yves Reginster
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging clinical and experimental research 31 (7) (2019)
Germain Honvo, Jean-Yves Reginster, Véronique Rabenda, Anton Geerinck, Ouafa Mkinsi, Alexia Charles, Rene Rizzoli, Cyrus Cooper, Bernard Avouac, Olivier Bruyère
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs & aging 36 (Suppl 1) (2019)
Eugeniusz Kucharz, Sándor Szántó, Mariana G Ivanova, Milan Petronijević, Ksenija Šimnovec, Marcin Domżalski, Lucia Muraca, Zdravko Kamenov, Jerzy Konstantynowicz, Goran Radunovic, Boris Šteňo, Rumen Malinov Stoilov, Rasto Stok, Radovan Vrana, Olivier Bruyère, Cyrus Cooper, Jean-Yves Reginster
Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis. Rheumatology international 39 (7) (2019)
Germain Honvo, Jean-Yves Reginster, Francois Rannou, Xavier Rygaert, Anton Geerinck, Véronique Rabenda, Tim McAlindon, Alexia Charles, Nicholas Fuggle, Cyrus Cooper, Elizabeth Curtis, Nigel Arden, Bernard Avouac, Olivier Bruyère
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs & aging 36 (Suppl 1) (2019)
Germain Honvo, Olivier Bruyère, Jean-Yves Reginster
Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis. Aging clinical and experimental research 31 (8) (2019)
Germain Honvo, Victoria Leclercq, Anton Geerinck, Thierry Thomas, Nicola Veronese, Alexia Charles, Véronique Rabenda, Charlotte Beaudart, Cyrus Cooper, Jean-Yves Reginster, Olivier Bruyère
Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs & aging 36 (Suppl 1) (2019)
Olivier Bruyère, Cyrus Cooper, Nasser M Al-Daghri, Elaine M Dennison, René Rizzoli, Jean-Yves Reginster
Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging clinical and experimental research 30 (2) (2017)
Justine Slomian, Patrick Emonts, Lara Vigneron, Alessandro Acconcia, Jean-Yves Reginster, Mina Oumourgh, Olivier Bruyère
Meeting the Needs of Mothers During the Postpartum Period: Using Co-Creation Workshops to Find Technological Solutions. JMIR research protocols 6 (5) (2017)
Geoff Appelboom, Blake E Taylor, Eliza Bruce, Clare C Bassile, Corinna Malakidis, Annie Yang, Brett Youngerman, Randy S D'Amico, Samuel S Bruce, Olivier Bruyère, Jean-Yves Reginster, Emmanuel L P Dumont, E Sander Connolly
Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization. JMIR mHealth and uHealth 3 (3) (2015)